← Back to all signals

IART INTEGRA LIFESCIENCES HOLDINGS CORP

Last updated: May 11, 2026

Execution Consistency

Did the company actually spend money buying back stock in 3+ of the last 4 quarters?

Bought back stock in 2/4 quarters. Q3 2025: $0M, Q3 2024: $125M, Q2 2024: $0M, Q1 2024: $150M

🐻

Execution Acceleration

Is the most recent quarter's buyback spend more than 15% above the trailing average?

Latest quarter $0M vs trailing avg $92M (-100%)

🐻

Buyback vs FCF

What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.

Negative FCF ($-172M), buybacks not supported by cash flow

🐂

Buyback Intensity

How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.

Repurchased 5,200,000 shares = 6.7% of 77,796,903 outstanding (annualized)

Insider Buying

Are officers and directors buying stock with their own money on the open market?

1 open-market purchase by GRAVES JEFFREY A

  • GRAVES JEFFREY A () bought 9,000 shares at $11.35 on 2025-11-05

Insider-Buyback Convergence

Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.

Company buybacks in 2 quarters but insufficient insider buying

🐂

Insider Net Direction

Over the last 90 days, are insiders net buyers or net sellers on the open market?

Insiders bought $0M, sold $0M in the last 90 days (net buying)

Red Flag

Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.

No buyback-insider divergence detected